Review: Optimal use of biologics in the management of Crohn’s disease
Crohn’s disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago ha...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2010-05-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/1756283X09357579 |
| _version_ | 1818937148128100352 |
|---|---|
| author | Remo Panaccione MD, FRCPC Subrata Ghosh MD, FRCP, FRCP(E) |
| author_facet | Remo Panaccione MD, FRCPC Subrata Ghosh MD, FRCP, FRCP(E) |
| author_sort | Remo Panaccione MD, FRCPC |
| collection | DOAJ |
| description | Crohn’s disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago has offered a new option for patients failing conventional therapy. Over time, biologic therapy has also led to the desire to achieve treatment goals beyond the control of symptoms. In order to achieve short-term and long-term goals with these new agents, it is important to review how these therapies may be optimized for the best results. |
| first_indexed | 2024-12-20T05:47:21Z |
| format | Article |
| id | doaj.art-1a9720bc55674d969df192aaf62d239c |
| institution | Directory Open Access Journal |
| issn | 1756-283X |
| language | English |
| last_indexed | 2024-12-20T05:47:21Z |
| publishDate | 2010-05-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Gastroenterology |
| spelling | doaj.art-1a9720bc55674d969df192aaf62d239c2022-12-21T19:51:16ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-283X2010-05-01310.1177/1756283X09357579Review: Optimal use of biologics in the management of Crohn’s diseaseRemo Panaccione MD, FRCPCSubrata Ghosh MD, FRCP, FRCP(E)Crohn’s disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago has offered a new option for patients failing conventional therapy. Over time, biologic therapy has also led to the desire to achieve treatment goals beyond the control of symptoms. In order to achieve short-term and long-term goals with these new agents, it is important to review how these therapies may be optimized for the best results.https://doi.org/10.1177/1756283X09357579 |
| spellingShingle | Remo Panaccione MD, FRCPC Subrata Ghosh MD, FRCP, FRCP(E) Review: Optimal use of biologics in the management of Crohn’s disease Therapeutic Advances in Gastroenterology |
| title | Review: Optimal use of biologics in the management of Crohn’s disease |
| title_full | Review: Optimal use of biologics in the management of Crohn’s disease |
| title_fullStr | Review: Optimal use of biologics in the management of Crohn’s disease |
| title_full_unstemmed | Review: Optimal use of biologics in the management of Crohn’s disease |
| title_short | Review: Optimal use of biologics in the management of Crohn’s disease |
| title_sort | review optimal use of biologics in the management of crohn s disease |
| url | https://doi.org/10.1177/1756283X09357579 |
| work_keys_str_mv | AT remopanaccionemdfrcpc reviewoptimaluseofbiologicsinthemanagementofcrohnsdisease AT subrataghoshmdfrcpfrcpe reviewoptimaluseofbiologicsinthemanagementofcrohnsdisease |